SCHEMBL4975353

SCHEMBL4975353

O=C(O)N1CCCC(C(O)c2cccc(F)c2)C1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.42
DPP7 Q9UHL4 1/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
OPRL1 P41146 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
HTT P42858 1/20 0.40
REN P00797 4/20 0.40
SCD5 Q86SK9 1/20 0.40
KMT2A Q03164 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4975348 1.00 DPP4 (0.42) DPP4DPP7KDM4EALDH1A1HPGD
SCHEMBL4972425 0.86 DPP4 (0.41) DPP4DPP7KDM4EALDH1A1HPGD
SCHEMBL5508506 0.85 CHRM3 (0.46) KDM4EHPGDSMN1; SMN2KMT2A
SCHEMBL5508508 0.85 CHRM3 (0.46) KDM4EHPGDSMN1; SMN2KMT2A
SCHEMBL27689759 0.85 CHRM3 (0.46) KDM4EHPGDSMN1; SMN2KMT2A
SCHEMBL3968379 0.85 HPGD (0.42) ALDH1A1HPGDSMN1; SMN2REN
SCHEMBL971537 0.85 ALDH1A1 (0.44) DPP4DPP7KDM4EALDH1A1OPRM1
SCHEMBL3317847 0.85 ALDH1A1 (0.44) DPP4DPP7KDM4EALDH1A1OPRM1
SCHEMBL3317851 0.85 ALDH1A1 (0.44) DPP4DPP7KDM4EALDH1A1OPRM1
SCHEMBL971535 0.85 ALDH1A1 (0.44) DPP4DPP7KDM4EALDH1A1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101356156-B Aspartic protease inhibitors VITAE PHARMACEUTICALS INC 2012-12-05 CN disclosed
CN-101356156-A Aspartic protease inhibitors VITAE PHARMACEUTICALS INC (US) 2009-01-28 CN disclosed
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed